GWAS-related meQTLs across different cancer types
We identified 2,214,458 meQTLs that overlap with GWAS linkage disequilibrium (LD) regions (r² ≥ 0.5).
Cancer type
|
QTL type
|
tagSNP
|
Gene position (hg19)
|
Gene
|
p-value
|
|||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BLCA | cis | rs736408 | 0.812 | rs9324 | chr3:52825585 | T/C | cg15147215 | chr3:52552868 | STAB1 | -0.34 | -6.44 | -0.31 | 3.62E-10 | Bipolar disorder; |
BLCA | cis | rs9487051 | 0.872 | rs9487032 | chr6:109605323 | G/T | cg12927641 | chr6:109611667 | NA | -0.34 | -6.99 | -0.34 | 1.23E-11 | Reticulocyte fraction of red cells; |
BLCA | cis | rs9549367 | 0.737 | rs9549712 | chr13:113902355 | G/A | cg00898013 | chr13:113819073 | PROZ | -0.38 | -6.15 | -0.3 | 1.95E-9 | Platelet distribution width; |
BLCA | cis | rs1799949 | 0.965 | rs9897425 | chr17:41430179 | C/G | cg19454999 | chr17:41278357 | BRCA1;NBR2 | 0.55 | 9.63 | 0.44 | 8.87E-20 | Menopause (age at onset); |
BLCA | cis | rs6076065 | 0.748 | rs999068 | chr20:23376483 | G/A | cg11657817 | chr20:23433608 | CST11 | 0.32 | 6.9 | 0.33 | 2.18E-11 | Facial morphology (factor 15, philtrum width); |
BLCA | cis | rs11098499 | 0.754 | rs9991959 | chr4:120253773 | C/T | cg24375607 | chr4:120327624 | NA | -0.53 | -9.37 | -0.43 | 6.42E-19 | Corneal astigmatism; |
BLCA | trans | rs7613875 | 0.6 | rs1061474 | chr3:50144951 | T/C | cg21659725 | chr3:3221576 | CRBN | -0.55 | -8.8 | -0.41 | 4.85E-17 | Body mass index; |
BLCA | trans | rs61931739 | 0.534 | rs11052974 | chr12:34029877 | T/G | cg13010199 | chr12:38710504 | ALG10B | 0.52 | 8.36 | 0.39 | 1.19E-15 | Morning vs. evening chronotype; |
BLCA | trans | rs877282 | 0.898 | rs11253353 | chr10:766862 | C/A | cg13042288 | chr15:90349979 | ANPEP | -0.5 | -6.56 | -0.32 | 1.77E-10 | Uric acid levels; |
BLCA | trans | rs72820985 | 0.542 | rs11645677 | chr16:80834612 | A/G | cg07185038 | chr12:58165658 | FAM119B;METTL1 | 0.41 | 6.18 | 0.3 | 1.66E-9 | Breast cancer; |
BLCA | trans | rs72820985 | 0.542 | rs11645677 | chr16:80834612 | A/G | cg16353345 | chr18:55289325 | NARS | 0.41 | 6.5 | 0.32 | 2.57E-10 | Breast cancer; |
BLCA | trans | rs72820985 | 0.542 | rs11645677 | chr16:80834612 | A/G | cg27653394 | chr10:102758893 | LZTS2 | 0.4 | 6.17 | 0.3 | 1.77E-9 | Breast cancer; |
BLCA | trans | rs6427356 | 1 | rs1176555 | chr1:157136541 | C/G | cg06742800 | chr2:27255708 | TMEM214 | -0.54 | -7.74 | -0.37 | 9.37E-14 | Attention deficit hyperactivity disorder and conduct disorder; |
BLCA | trans | rs6427356 | 1 | rs1176555 | chr1:157136541 | C/G | cg13323097 | chr1:205649211 | SLC45A3 | -0.45 | -6.29 | -0.31 | 8.77E-10 | Attention deficit hyperactivity disorder and conduct disorder; |
BLCA | trans | rs11997175 | 0.846 | rs11776207 | chr8:33765126 | G/T | cg06748231 | chr5:1112251 | SLC12A7 | -0.39 | -6.27 | -0.31 | 9.95E-10 | Body mass index; |